Centene Corporation (LON:0HVB)
35.99
+0.79 (2.23%)
At close: Oct 20, 2025
Centene Revenue
Centene had revenue of $42.47 billion USD in the quarter ending June 30, 2025, with 16.56% growth. This brings the company's revenue in the last twelve months to $159.67 billion, up 10.73% year-over-year. In the year 2024, Centene had annual revenue of $147.17 billion with 4.09% growth.
Revenue (ttm)
$159.67B
Revenue Growth
+10.73%
P/S Ratio
0.11
Revenue / Employee
$2.64M
Employees
60,500
Market Cap
13.03B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 147.17B | 5.78B | 4.09% |
Dec 31, 2023 | 141.39B | 5.39B | 3.97% |
Dec 31, 2022 | 136.00B | 17.43B | 14.70% |
Dec 31, 2021 | 118.57B | 14.29B | 13.71% |
Dec 31, 2020 | 104.28B | 33.47B | 47.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
Hikma Pharmaceuticals | 2.35B |
ConvaTec Group | 1.72B |
Spire Healthcare Group | 1.55B |
Genus | 672.80M |
Centene News
- 2 days ago - Managed Care Insurers Trading Down Ahead Of Earnings Season - Seeking Alpha
- 3 days ago - Peter Lynch Detailed Fundamental Analysis - CNC - Nasdaq
- 5 days ago - Centene (CNC) Expands Medicare Advantage Plans Across 32 States for 2026 - GuruFocus
- 5 days ago - Centene bucks industry trend as Medicare Advantage offerings remain stable for 2026 - Seeking Alpha
- 5 days ago - Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026 - PRNewsWire
- 6 days ago - Graphene Investments Dumps 55K CNC Shares for $3 Million - Nasdaq
- 6 days ago - Morgan Stanley Raises Price Target for Centene (CNC) to $38 | CNC Stock News - GuruFocus
- 7 days ago - Oakmark Global Select Fund adds Dassault, exits Centene in Q3 - Seeking Alpha